palbociclib,bortezomib,venetoclax,ruxolitinib,trametinib,sorafenib
roche,pfizer,bayer,incyte,takeda,abbvie,novartis
['trametinib', 'venetoclax', 'palbo', 'ruxolitinib', 'bortezomib', 'rux,(-crux),(-trux),(-deruxtecan)', 'sorafenib', 'borte']
venetoclax with novel partners in ex vivo samples. #ash22 
Oncologist at @NeoplasicasPeru. Lymphoma, MM, leukemia and HSCT. @ASCO IESG 20-24. HM Guideline Advisory Group. GCSRT and EWHC at Harvard  Med 20-21. IDEA 2015.